Our previous study showed that ERα was essentially involved in chemoresistance, which may be attributed to its role as a nuclear transcriptional factor in regulating some important tumour drug‐resistant genes.10 Thus, we detected the expression of ERα in ER+ breast cancer cells stimulated by E2. The gene discussed is ESR1; the disease is breast carcinoma.